We have previously demonstrated that capsaicin exerts a synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells and with docetaxel in prostate cancer cells through AMPK activation [2,40]. The gene discussed is PRKAA1; the disease is prostate carcinoma.